Skip to main content
BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
35.11
-1.29 (-3.54%)
At close: Mar 28, 2025, 4:00 PM
34.91
-0.20 (-0.57%)
After-hours: Mar 28, 2025, 7:16 PM EDT

BridgeBio Pharma Revenue

In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth. BridgeBio Pharma had revenue of $5.88M in the quarter ending December 31, 2024, with 237.08% growth.

Revenue (ttm)
$221.90M
Revenue Growth
+2,285.27%
P/S Ratio
29.44
Revenue / Employee
$303,975
Employees
730
Market Cap
6.68B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024221.90M212.60M2,285.27%
Dec 31, 20239.30M-68.35M-88.02%
Dec 31, 202277.65M7.93M11.38%
Dec 31, 202169.72M61.47M745.14%
Dec 31, 20208.25M-32.31M-79.66%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BBIO News

More News